Hot Information Technology Companies To Buy For 2015

Hot Information Technology Companies To Buy For 2015: Ishares Nasdaq Biotechnology (IBB)

iShares Nasdaq Biotechnology Index Fund (the Fund) seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index consists of securities of NASDAQ-listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, and which also meet other eligibility criteria. The Index is one of the eight sub-indices of the NASDAQ Composite, which measures all common stocks listed on The NASDAQ Stock Market, Inc.

The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. The Fund's investment advisor is Barclays Global Fund Advisors.

Advisors' Opinion:

• [By Jake Mann]

  Biotech looks like one of the sectors of the future. I like iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB). In general, I am looking for a positive 2015 with most upside in first half and flat second half.

• [By Ben Levisohn]

  Shares of Gilead Sciences are little changed at $105.90 at 12:48 p.m. That leaves 31% of upside to Werber’s target price of $139. The iShares Nasdaq Biotechnology ETF (IBB) has dropped 0.6% to $273.60 today.

• [By Ben Levisohn]

  I mean, just look at these returns: Gilead Sciences (GILD) has gained 41% so far this year as investors appear to have put their Sovaldi worries behind them; InterMune (ITMN) has quintupled in 2014 after Roche agreed to purchase it for $8.3 billion; and Intercept Pharmaceuticals (ICPT) has surged 350% as drug trials have been surprisingly good. All told, the iShares Nasdaq Biotechnology ETF (IBB) has risen 21%, more than double the S&P 500′s 8.3% rise.

sour! ce from Top Stocks For 2015:http://www.topstocksblog.com/hot-information-technology-companies-to-buy-for-2015.html